By analyzing blood samples of CLL and DLBCL patients, we observed a higher proportion of PD-1-expressing CD4+ T cells in both patient groups compared to HC thus confirming published data [6–10]. The gene discussed is PDCD1; the disease is diffuse large B-cell lymphoma.